A wide array of biotechnology and biopharmaceutical enterprises focus heavily on developing targeted therapies for autoimmune conditions. Prominent commercial leaders and clinical pioneers include AbbVie, Johnson & Johnson, Amgen, Bristol Myers Squibb, Vertex Pharmaceuticals, and cell therapy innovators like Artiva Biotherapeutics and Cabaletta Bio.